维普期刊资源整合服务平台（V6.5）

25篇 您的检索式：作者名="Kyte JA"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patients 显示文摘	Mu U Kyte JA Kvalheim G Aamdal S	2005	Br J Cancer2005，93，7：	1
2	Phase I / II trial of melanoma therapy with dendritic cells transfected with autologous tumor - mRNA 显示文摘	Kyte JA Mu L Aamdal S	2006	Cancer Gene Ther2006，13，10：	1
3	Phase Ⅰ/Ⅱ trial of melanoma therapy with dendritic ceils transfected with autologons tumormRNA显示文摘	Kyte JA Mu L Aamdal S et:al	2006	CancerGeneTherapy2006，13，10：	1
4	Cancer vaccination with telomerase peptide GV1001显示文摘	Kyte JA	2009	Expert Opin Investig2009，18，5：	1
5	Telomerase peptide vaccination inNSCLC:a phase II trial in stage 01 patients vaccinated after chemora-diotherapy and an 8-year update on a phase I / II trial 显示文摘	Brunsvig PF Kyte JA Kersten C	2011	Clin CancerRes2011，17，21：	1
6	Telomerase peptide vaccinationcombined with temozolomide:a clinical trial in stage IV melanoma pa-tients显示文摘	Kyte JA Gaudemack G Dueland S	2011	Clin Cancer Res2011，17，13：	1
7	Phase Ⅰ/Ⅱ trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA显示文摘	Kyte JA Mu L Aamdal S	2006	Cancer Gene Ther2006，13，10：	1
8	PhaseⅠ/Ⅱtrial of melanomatherapy with dendritic cells transfected with autologous tumor-mRNA显示文摘	Kyte JA Mu L Aamdal S	2006	Cancer Gene Ther2006，13，10：	1
9	Immunothempy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostale cancer patients显示文摘	Mu LJ Kyte JA Kvalheim G	2005	Br J Cancer2005，93，7：	1
10	Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patients显示文摘	Mu LJ Kyte JA Kvalheim G	2005	Br J Cancer2005，93，7：	1
11	Preclinical fullscale evaluation of dendritic cells transfected with autologous tumor-mRNA for melanoma vaccination显示文摘	Kvalheim G Aamdal S	2005	Cancer Gene Ther2005，12，6：	1
12	Phase I / II trial of melanoma therapywith dendritic cells transfected with autologous tumor mR- NA显示文摘	Kyte JA Mu L Aamdal S	2006	Cancer Gene Ther2006，13，10：	1
13	Immunotherapy with allotumour mRNA - transfected dendritic cells in androgen - resistant prostate cancer patients 显示文摘	Mu LJ Kyte JA Kvalheim G	2005	Br J Cancer2005，93，7：	1
14	Unconventional cytokine profiles and development of T cell memory in long-term survivors after cancer vaccination 显示文摘	Kyte JA Trachsel S Risberg B	2009	Cancer Immunol Immunother2009，58，10：	1
15	Telomerase peptide vaccination combined with temozolomide:a clinical trial in stage Ⅳ melanoma patients显示文摘	Kyte JA Gaudemack G Dueland S		0，，13：	1
16	Cancer vaccination with telomerase peptide GV1001 显示文摘	Kyte JA	2009	Expert Opin Investig Drags2009，18，5：	1
17	Phase I/II trial of melanoma therapy with dendritic ceils transfected with autologous tumor-mRNA显示文摘	Kyte JA Mu L Aamdal S	2006	Cancer gene therapy2006，13，10：	1
18	Telomerase Peptide Vaccination in NSCLC: A Phase II Trial in Stage III Patients Vaccinated after Chemoradiotherapy and an 8-Year Update 'on a Phase I/II Trial显示文摘	Brunsvig PF Kyte JA Kersten C	2011	Clinical Cancer''Research2011，17，21：	1
19	Phase I/II trial of melanoma thera- py with dendritic ceils transfected with autologous tumor-mRNA 显示文摘	Kyte JA Mu L Aamdal S	2006	Cancer Gene Ther2006，13，10：	1
20	Immuno-gene therapy of Cancer with tumour-mRNA transfected dendritic cells显示文摘	Kyte JA Gaudernack G	2006	Cancer Immunol Immunother2006，55，11：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示